Uniting experts across pharma, biotech and academia, the Precision Medicine in Inflammatory Bowel Disease Summit is your only dedicated forum to benchmark novel markers and innovative technology across RNA-sequencing, metabolomics, proteomics and more. Be involved in this cross-indication collaboration to translate basic immunology into clinical response and develop your biomarker strategy early.
The meeting will showcase novel technologies to overcome disease heterogeneity, develop more targeted therapeutics and pave the way for more precise patient care in autoimmune inflammatory diseases.
Developed in collaboration with key industry thought leaders from AbbVie, Celsius Therapeutics, Crohn’s & Colitis Foundation, Janssen, Prometheus Bioscience and more, leave this meeting with key lessons learned to improve your clinical trial efficacy and patient care for those suffering from IBD.
The race is on to approve precision medicine approaches in IBD, don’t miss your opportunity to unite with your peers to discuss and overcome the hurdles preventing approval.
Event name: Precision Medicine in Inflammatory Bowel Disease Summit
Event date: January 30 – February 1, 2023
Event venue: Embassy Suites Boston Logan Airport, 207 Porter Street, Boston MA, 021128
Event organizers: Hanson Wade Group
Contact number: (+1) 617 455 4188
Email: info@hansonwade.com
URL: https://ter.li/9g3fb4
Embassy Suites Boston Logan Airport , Boston, USA